Modulation of Protein-Interaction States through the Cell Cycle
2018 · Cell · 169 citations
https://doi.org/10.1016/j.cell.2018.03.065
X
Xavier Bisteau
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
48
Papers
1.5K
Citations
20
h-index
22
i10-index
Xavier Bisteau is an academic researcher from Université Libre de Bruxelles. The author has contributed to research in topics: Cancer-related Molecular Pathways & Microtubule and mitosis dynamics & Advanced Breast Cancer Therapies. The author has an h-index of 20, co-authored 41 publications.
ORCID: 0000-0002-8896-5098Papers by this author
worksThe CDK4/CDK6 inhibitor PD0332991 paradoxically stabilizes activated cyclin D3-CDK4/6 complexes
2014 · Cell Cycle · 43 citations
https://doi.org/10.4161/15384101.2014.946841
Loss of Cyclin-dependent Kinase 2 in the Pancreas Links Primary β-Cell Dysfunction to Progressive Depletion of β-Cell Mass and Diabetes
2017 · Journal of Biological Chemistry · 42 citations
https://doi.org/10.1074/jbc.m116.754077
JNKs function as CDK4-activating kinases by phosphorylating CDK4 and p21
2017 · Oncogene · 30 citations
https://doi.org/10.1038/onc.2017.7
SHIP2–PLK1 crosstalk promotes sensitivity to dual inhibition in esophageal squamous cell carcinoma
2025 · Molecular Cancer · 1 citations
https://doi.org/10.1186/s12943-025-02454-z
Specific inhibition of CDK7 by 1-NMPP1 prevents the main phosphorylation of p21, which is performed <i>in vitro</i> by both CDK4 and CDK2.
2015 · Figshare · 0 citations
https://doi.org/10.1371/journal.pgen.1003546.g003
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat